Total Payments
$33,103
2023 Payments
$23.00
Companies
12
Transactions
40
Payment Breakdown by Category
Other$24,609 (74.3%)
Travel$6,873 (20.8%)
Food & Beverage$1,609 (4.9%)
Education$11.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,609 | 9 | 74.3% |
| Travel and Lodging | $6,873 | 12 | 20.8% |
| Food and Beverage | $1,609 | 18 | 4.9% |
| Education | $11.92 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $28,701 | 23 | $0 (2019) |
| Genentech, Inc. | $1,838 | 3 | $0 (2017) |
| Stemline Therapeutics Inc. | $1,530 | 3 | $0 (2020) |
| Array BioPharma Inc. | $700.00 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $114.99 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $114.58 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $24.72 | 2 | $0 (2019) |
| ABBVIE INC. | $23.00 | 1 | $0 (2023) |
| Genentech USA, Inc. | $19.07 | 1 | $0 (2017) |
| Amgen Inc. | $12.65 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.00 | 1 | ABBVIE INC. ($23.00) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $1,530 | 3 | Stemline Therapeutics Inc. ($1,530) |
| 2019 | $29,352 | 27 | Novartis Pharmaceuticals Corporation ($28,602) |
| 2018 | $214.37 | 3 | E.R. Squibb & Sons, L.L.C. ($114.99) |
| 2017 | $1,971 | 5 | Genentech, Inc. ($1,838) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 08/12/2020 | Stemline Therapeutics Inc. | — | Travel and Lodging | Cash or cash equivalent | $937.27 | General |
| 08/12/2020 | Stemline Therapeutics Inc. | — | Travel and Lodging | In-kind items and services | $296.96 | General |
| 08/12/2020 | Stemline Therapeutics Inc. | — | Food and Beverage | Cash or cash equivalent | $296.09 | General |
| 11/13/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $437.04 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | In-kind items and services | $376.45 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $59.38 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,240.00 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | In-kind items and services | $536.50 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $474.04 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | In-kind items and services | $376.44 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $110.44 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | Cash or cash equivalent | $68.09 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,638.00 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,930.00 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $917.95 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $57.30 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $562.97 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $97.85 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,638.00 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $518.60 | General |
| Category: ONCOLOGY | ||||||
About Dr. Arthur Frankel, MD
Dr. Arthur Frankel, MD is a Hematology & Oncology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013977487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Frankel, MD has received a total of $33,103 in payments from pharmaceutical and medical device companies, with $23.00 received in 2023. These payments were reported across 40 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,609).
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology, Internal Medicine
- Location Dallas, TX
- Active Since 03/28/2006
- Last Updated 09/18/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013977487
Products in Payments
- MEKINIST (Drug) $27,063
- Non-Covered Product (Drug) $1,838
- Braftovi (Drug) $700.00
- IMFINZI (Drug) $114.58
- OPDIVO (Biological) $96.31
- KEYTRUDA (Biological) $24.72
- VENCLEXTA (Drug) $23.00
- COTELLIC (Drug) $19.07
- SPRYCEL (Drug) $18.68
- Nplate (Biological) $12.65
- IBRANCE (Drug) $12.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Dallas
Dr. Christopher Maisel, Md, MD
Hematology & Oncology — Payments: $884,793
Hematology & Oncology $884,793
Dr. Houston Holmes, M.d, M.D
Hematology & Oncology — Payments: $261,905
Hematology & Oncology $261,905
Dr. Kartik Konduri, Md, MD
Hematology & Oncology — Payments: $253,193
Hematology & Oncology $253,193
Dr. Farrukh Awan, M.d., M.s, M.D., M.S
Hematology & Oncology — Payments: $184,107
Hematology & Oncology $184,107
Dr. Joanne Blum, M.d, M.D
Hematology & Oncology — Payments: $183,987
Hematology & Oncology $183,987
Joan Schiller, Md, MD
Hematology & Oncology — Payments: $174,115
Hematology & Oncology $174,115